Literature DB >> 11190044

Vision impairment predicts five-year mortality.

H R Taylor1, C A McCarty, M B Nanjan.   

Abstract

PURPOSE: To describe predictors of mortality in the 5-year follow-up of the Melbourne Visual Impairment Project (VIP) cohort.
METHODS: The Melbourne VIP was a population-based study of the distribution and determinants of age-related eye disease in a cluster random sample of Melbourne residents aged 40 years and older. Baseline examinations were conducted between 1992 and 1994. In 1997, 5-year follow-up examinations of the original cohort commenced. Causes of death were obtained from the National Death Index for all reported deaths.
RESULTS: Of the original 3,271 participants, 231 (7.1%) were reported to have died in the intervening 5 years. Of the remaining 3,040 participants eligible to return for follow-up examinations, 2,594 (85% of eligible) did participate, 51 (2%) had moved interstate or overseas, 83 (3%) could not be traced, and 312 (10%) refused to participate. Best corrected visual acuity < 6/12 and cortical cataract were associated with a significantly increased risk of mortality, as were increasing age, male sex, increased duration of cigarette smoking, increased duration of hypertension, and arthritis.
CONCLUSIONS: Even mild visual impairment increases the risk of death more than twofold.

Entities:  

Mesh:

Year:  2000        PMID: 11190044      PMCID: PMC1298215     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  29 in total

1.  Expectation of life for persons with glaucoma.

Authors:  N B BELLOC
Journal:  J Chronic Dis       Date:  1963-02

2.  The epidemiology of cataract in Australia.

Authors:  C A McCarty; B N Mukesh; C L Fu; H R Taylor
Journal:  Am J Ophthalmol       Date:  1999-10       Impact factor: 5.258

3.  High intraocular pressure and survival: the Framingham Studies.

Authors:  R Hiller; M J Podgor; R D Sperduto; P W Wilson; E Y Chew; R B D'Agostino
Journal:  Am J Ophthalmol       Date:  1999-10       Impact factor: 5.258

4.  Survivorship and causes of death among the blind.

Authors:  E Rogot; I D Goldberg; H Goldstein
Journal:  J Chronic Dis       Date:  1966-02

5.  Lens opacity and mortality in diabetes.

Authors:  D L Cohen; H A Neil; J Sparrow; M Thorogood; J I Mann
Journal:  Diabet Med       Date:  1990-08       Impact factor: 4.359

6.  Lens changes and survival in a population-based study.

Authors:  M J Podgor; G H Cassel; W B Kannel
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

7.  Cataract and survival in an elderly nondiabetic population.

Authors:  J R Thompson; J M Sparrow; J M Gibson; A R Rosenthal
Journal:  Arch Ophthalmol       Date:  1993-05

8.  National five-year mortality after inpatient cataract extraction.

Authors:  D A Street; J C Javitt
Journal:  Am J Ophthalmol       Date:  1992-03-15       Impact factor: 5.258

9.  Increased mortality among elderly patients undergoing cataract extraction.

Authors:  R P Hirsch; B Schwartz
Journal:  Arch Ophthalmol       Date:  1983-07

10.  A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM.

Authors:  A Neil; M Hawkins; M Potok; M Thorogood; D Cohen; J Mann
Journal:  Diabetes Care       Date:  1993-07       Impact factor: 19.112

View more
  16 in total

1.  Association between abnormal contrast sensitivity and mortality among people with acquired immunodeficiency syndrome.

Authors:  Gary N Holland; Peter J Kappel; Mark L Van Natta; Frank J Palella; Alice T Lyon; Kayur H Shah; Peter R Pavan; Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-05       Impact factor: 5.258

2.  A longitudinal analysis of factors associated with age-related cataract among older Australian women: a cohort study of 7851 older Australian women 79-90 years.

Authors:  Mitiku Teshome Hambisa; Xenia Dolja-Gore; Julie E Byles
Journal:  Ir J Med Sci       Date:  2022-08-17       Impact factor: 2.089

3.  Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study.

Authors:  E-M Chia; P Mitchell; E Rochtchina; S Foran; J J Wang
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

4.  Prevalence and Causes of Unilateral Vision Impairment and Unilateral Blindness in Australia: The National Eye Health Survey.

Authors:  Joshua Foreman; Jing Xie; Stuart Keel; Ghee Soon Ang; Pei Ying Lee; Rupert Bourne; Jonathan G Crowston; Hugh R Taylor; Mohamed Dirani
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389

5.  Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.

Authors:  Traci E Clemons; Natalie Kurinij; Robert D Sperduto
Journal:  Arch Ophthalmol       Date:  2004-05

6.  Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.

Authors:  Chandana Papudesu; Traci E Clemons; Elvira Agrón; Emily Y Chew
Journal:  Ophthalmology       Date:  2017-11-16       Impact factor: 12.079

7.  Aging With Vision Loss: A Framework for Assessing the Impact of Visual Impairment on Older Adults.

Authors:  Bonnielin K Swenor; Moon J Lee; Varshini Varadaraj; Heather E Whitson; Pradeep Y Ramulu
Journal:  Gerontologist       Date:  2020-08-14

8.  Long-term visual outcomes of craniopharyngioma in children.

Authors:  Michael J Wan; Michal Zapotocky; Eric Bouffet; Ute Bartels; Abhaya V Kulkarni; James M Drake
Journal:  J Neurooncol       Date:  2018-01-17       Impact factor: 4.130

9.  Association of blindness and hearing impairment with mortality in a cohort of elderly persons in a rural area.

Authors:  Nilesh Agrawal; M Kalaivani; Sanjeev K Gupta; Puneet Misra; K Anand; Chandrakant S Pandav
Journal:  Indian J Community Med       Date:  2011-07

10.  Vision before and after scharioth macular lens implantation in patients with AMD: an electrophysiological study.

Authors:  Jan Kremláček; Jana Nekolová; Markéta Středová; Jana Langrová; Jana Szanyi; Miroslav Kuba; Zuzana Kubová; František Vít; Petr Voda; Martina Veselá; Naďa Jirásková
Journal:  Doc Ophthalmol       Date:  2021-01-03       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.